• Richard Sánchez, MD, MPH, FAAP CEO for Isommune LLC.
Dr. Sánchez is an internationally recognized health care executive specializing in managed care operations, health care policy, and the
assessment of emerging technology and pharmacy innovations. He has most recently served as Senior Vice President and Chief Medical Officer at
Molina Healthcare and Health Choice. There he managed all of their clinical programs. Dr. Sánchez was responsible for the company’s medical
affairs, quality and pharmacy departments’ operations and quality initiatives. Prior to assuming this position in 2015, Dr. Sánchez was chief
medical officer for Molina Healthcare of California and Molina Healthcare of Utah. He has 20 years of experience in managed health care, having worked as
chief medical officer at Mercy Care Plan (Schaller Anderson), Coventry Health Care, Humana and Blue Cross Blue Shield in
New York City. Dr. Sánchez has also provided strategic and tactical leadership to several of the nation’s leading managed care organizations,
including: AltaMed, Community Health Plan of Washington, Family Health Plan of Chicago, Aloha Care, U Care of Minnesota, Health Integrated,
BCBS of North Carolina, McKesson, Iasis Healthcare, Steward Health Choice and AxisPoint. Dr. Sánchez also served eight years as public health
commissioner for the city and county of San Francisco, California. Dr. Sánchez received his medical degree from the University of California School
of Medicine at San Francisco. He then completed a pediatric residency at Children’s Hospital of Los Angeles. He received a Master of
Public Health from the University of California, Berkeley.
• James Hoxter Isommune Founder. Mr. Hoxter is a co-founder and President of Isommune LLC, a cancer research and vaccine therapeutics
company. Additionally he founded Conversio Health, a nationwide specialty pharmacy focused on patient care, there he provides extensive advisory while
serving on the Board of Directors for four different companies. Mr. Hoxter has founded and
grown several companies, including Central Coast Medical Supply and Pacific Coast Pharmacy. He has over 35 years of experience of building
successful businesses within the healthcare industry. Mr. Hoxter carries extensive medical experience from working within the operating
room and as a licensed Respiratory Care Practitioner in neonatal transport/services and acute care. Mr. Hoxter and his wife have initiated
non-profit foundations, one of which rebuilds schools serving in underprivileged communities.
• Kelly Frazer, PhD CSO for Isommune LLC.
Kelly A. Frazer, PhD Isommune Founder and Science Advisory Board Member. Dr. Frazer is a professor and
the founding chief of the Division of Genome Information Sciences in the Department of Pediatrics, and Director of UC San Diego’s
Institute for Genomic Medicine. Dr. Frazer is an internationally known leader in the field of genomic biology. She obtained her
Doctorate of Philosophy in Genetics from University of California San Francisco in 1993. Her research mission is to identify common
and rare genetic variants that are associated with human disease in order to functionally assess their role in disease pathogenesis,
progression, and prognosis using innovative bioinformatics and computational approaches. Prior to joining UCSD in 2009, Dr. Frazer
was Professor of Translational Genomics at the Scripps Research Institute and, previously, Vice President of Genomic Biology at
Perlegen Sciences. Dr. Frazer has spent the past 30 years studying various aspects of functional and structural human genomics,
and her contributions include pioneering cross-species DNA sequence comparisons between humans and mice, generating the content now
publicly available in the “HapMap Phase II,” and developing novel methods for identifying and functionally annotating variants
underlying GWAS signals.
• Dennis Carson, MD Isommune Founder and Science Advisory Board Member.
Emeritus Professor of Medicine, University of California San Diego Moores Cancer Center, Professor of Medicine. Dr. Carson
served as the Associate Dean for Health Sciences and the Director of Moores Cancer Center at UCSD for 8 years. Dr. Carson is the
cofounder and director of many biotechnical companies pertaining to cancer research as well as being an inventor of
78 US-issued patents. His career has focused on the discovery of new targets in oncology, immunology and infectious
diseases. After completing his Doctor of Medicine at Columbia University, and Internal Medicine at University of California
San Diego he received post-doctoral training in Immunology and Genetics at the Salk Institute and National Institutes of
Health. His specialties span basic and translational research in the fields of autoimmune disorders, hematological cancers,
solid tumors, leukemias, lymphomas, breast cancer, melanoma, innate immunity, and vaccine development involving the use of
molecular markers. He currently directs a large grant from National Institute of Health in immunology drug discovery and development.
• Robert Eversman General Manager and Member of the Business Advisory Council for Isommune LLC.
Mr. Eversman began as a laboratory assistant for the Chemistry Department at Lawrence Livermore National Laboratories before going on to
receive his Bachelor of Science in Manufacturing Engineering from California Polytechnic State University, San Luis Obispo. He has held
positions in project management, new product design and manufacturing, software design and implementation, information technology, and new
infrastructure installations. Mr. Eversman has assisted in establishing pharmaceutical and defense related businesses, with his most recent
endeavors having an emphasis on finance, analytics, and business operations.
